medAI Times

Three days after launch, Washington pulled the plug on Claude's two most powerful models.Run time: 5:38In today's episode:U.S. government forces Anthropic to disable Fable 5, Mythos 5General chatbots beat dedicated medical AI tools in Nature MedicineSIIM: AI nails the numbers, fumbles the judgmentFirst AI-formulated drug enters a Phase 1 trialTopol: 44 trials, still not standard practiceAnthropic credit split and model retirements go live todayGPT-5.6 and Gemini 3.5 Pro still stuck in previewTL;DR:Washington issued Anthropic an export-control order three days after launch, forcing it to disable Fable 5 and Mythos 5 for all customers — the model biomedical labs were using for drug design is gone for now.A Nature Medicine head-to-head found general-purpose LLMs beat OpenEvidence and UpToDate Expert AI across all three test rounds, with clinicians preferring them; the dedicated tools failed on clarity and safety-critical omissions.Radiologists at SIIM 2026 confirmed top LLMs exceed 95% on numerical extraction from scans but still make confident medical-knowledge errors — arithmetic isn't the weak link, judgment is.Sources cited:Nature MedicineAuntMinnieContract PharmaMedscapeGround TruthsCrescendo AI news roundupAnthropicReleasebotEssa MamdaniSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

An AI just spotted breast cancer in scans taken six years before diagnosis.Run time: 20:02In today's episode:AI sees breast cancer six years before diagnosisStanford crowd cooled on AI scribes after debateMost clinicians admit using unapproved AI toolsSaudi hospital shows off practical AI at HLTH EuropeStates move to regulate AI in insurance approvalsStanford and Mayo read tumors from a blood drawAnthropic splits subscription and API credits June 15xAI's Grok V9 lands mid-June, built on Cursor dataGemini 3.5 Pro still waiting on its June releaseTL;DR:A Radiology study found three FDA-cleared mammography AIs flagged signs of breast cancer up to six years before diagnosis in about one in five cancers — retrospective, but a big, clean dataset.The honest counter-current: Stanford clinicians' support for AI scribes dropped from 69% to 54% after a live debate, and a new survey says ~72% of healthcare staff reach for unapproved "shadow AI" when sanctioned tools fall short.Anthropic is splitting subscription and programmatic usage into separate credit pools on June 15 and retiring Opus 4.1 on August 5 — plan your pipelines now.Sources cited:EurekAlert / RadiologyStanford MedicineWolters KluwerGlobeNewswireTransparency CoalitionReleasebotTechTimesTechTimesSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

Anthropic just handed drug labs a model that designs molecules ten times faster.Run time: 13:30In today's episode:Ambient AI scribe cuts clinician burnout in randomized trialPhilips survey: AI saves sixteen workdays, training lagsAIRS SwiftMR wins wider FDA MRI clearanceMount Sinai launches AI cancer trial-matching toolNature Medicine: AI diagnosis accuracy swings fourfoldTopol says every mammogram should use AIAnthropic ships Fable 5, its strongest public modelClaude Code adds parallel-subagent dynamic workflowsGPT-5.6 and Gemini 3.5 Pro expected this monthTL;DR:A pragmatic RCT of an ambient AI scribe cut clinician exhaustion and documentation time without degrading note quality or billing accuracy — the kind of evidence the field keeps promising and rarely delivers.Anthropic released Claude Fable 5 (and the unlocked Mythos 5 for vetted bio/security researchers); scientists preferred Mythos 5's molecular-biology hypotheses over Opus-class output ~80% of the time, with a documented ~10x drug-design speedup.Philips' Future Health Index says AI already saves clinicians 16 working days a year — while 70% of those same clinicians call their AI training inadequate or nonexistent.Sources cited:NEJM AIGlobeNewswireDiagnostic ImagingMount SinaiNature MedicineGround TruthsAnthropicReleasebotEssa MamdaniPrimerSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

Two hundred AI-designed drugs are now in human trials. Not one is approved.Run time: 20:11In today's episode:Two hundred AI-discovered drugs in trials, zero approvedFDA clears Clarius bedside ejection-fraction AIGE HealthCare auto-contouring tool cleared for radiation planningPhilips and WellSpan sign seven-year AI imaging allianceJoint Commission launches first hospital AI certificationWHO weighs AI for health-policy decisionsAnthropic scales Mythos cyber program to fifteen countriesPerplexity lets its agent write its own search codeOpenAI says chat is dead, pivots to agentsTL;DR:The AI drug-discovery story matured into a counting problem: 200-plus candidates in clinical trials, roughly 56 in Phase 2 and 15 in Phase 3, and still zero FDA approvals. The 2026 Phase 3 readouts (zasocitinib, more rentosertib data) are the real test.Two more FDA clearances landed this week — Clarius for bedside ejection fraction, GE HealthCare for radiation-oncology auto-contouring — both narrow, both incremental, both shipping into existing workflows rather than replacing anyone.Governance caught up to deployment: the Joint Commission's Responsible Use of AI certification went live June 1, the first accreditation-grade AI program built specifically for health systems.Sources cited:BioMed NexusDAICITNPhilipsJoint CommissionWHOTechCrunchThe Decoderthe AAPM TG-275/TG-132 segmentation guidance and reviews on auto-segmentation QASubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

Mayo Clinic just decided to build its own medical A.I. and own it outright.Run time: 12:40In today's episode:Mayo Clinic and Microsoft build a frontier medical AIFDA clears Philips Elevate Plus AI ultrasoundAI reads cancer from ordinary tissue slidesPatients start using AI scribes in the exam roomAI arms race is inflating medical billingARPA-H funds first FDA-authorized clinical AI agentsEli Lilly fires up a thousand-GPU drug-discovery supercomputerAnthropic confidentially files to go publicGoogle ships Gemma 4, a laptop-class multimodal modelMicrosoft unveils MAI-Thinking-1 reasoning modelTL;DR:Mayo Clinic and Microsoft are co-building a healthcare-specific frontier model that Mayo will own and distribute via Azure Foundry — the most consequential "vertical foundation model" move yet in medicine.FDA cleared Philips Elevate Plus (AI ultrasound upgrade) and ARPA-H's ADVOCATE program is funding the first FDA-authorized agentic clinical AI — regulation is now actively shaping autonomous, not just diagnostic, AI.Anthropic confidentially filed an S-1 with the SEC (June 1), and Google shipped Gemma 4 12B, a multimodal model that runs locally on 16GB laptops.Sources cited:Microsoft / MayoPhilipsQIMR Berghofer / Nature CommunicationsSTATSTATARPA-HHealthcare context / NVIDIAAnthropicHipther AI DispatchNature Communications, "Robust and interpretable prediction of gene markers and cell types from spatial transcriptomics data"Subscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

Taiwan just put one and a half billion dollars behind robot nurses in real operating rooms.Run time: 20:53In today's episode:Taiwan and Foxconn launch 1.5 billion dollar clinical AI pushCoalition for Health AI ships 8 governance playbooksBostonGene brings 9 AI biomarker abstracts to ASCORoswell Park flags limits of AI clinical decision supportLancet Digital Health audits fairness metrics in clinical AIDana-Farber lands two plenaries at ASCO 2026Anthropic splits programmatic Claude usage into creditsNVIDIA unveils RTX Spark personal AI superchipTL;DR:Embodied AI moves from concept to a sovereign-scale deployment: NVIDIA, Foxconn, and Taiwan's hospital network commit $1.5B to put agentic and physical AI into real ORs and wards.CHAI publishes the most comprehensive open governance playbooks yet — eight modules for 100+ US health systems, mapped to the Joint Commission's coming AI certification.ASCO 2026 day three turns into AI day: BostonGene, Roswell Park, Dana-Farber, and a dedicated 4:30 PM AI session put oncology AI into the plenary spotlight.Sources cited:sourcesourcesourcesourcesourcesourcesourcesourcesourcesourceSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

ASCO twenty twenty-six opens today, and AI just lifted lung-cancer biomarker testing by twenty-four percent.Run time: 19:27In today's episode:Tempus Next lifts lung-cancer biomarker testing by twenty-four percentMayo Clinic brings thirty oncology AI studies to ASCOSylvester AI reads bone marrow to personalize myeloma therapyPenn Medicine flags AI gaps in patient cancer infoNEJM AI publishes MEDS open data standard for health AIAnthropic ships Claude Opus four point eight with dynamic workflowsAnthropic in talks to raise sixty-five billion at nine-hundred-sixty-five billionMythos moves toward broader release after ten thousand bugs foundTL;DR:ASCO 2026 kicks off in Chicago today — Tempus Next's AI clinical decision support lifted real-world biomarker-testing rates by +24% ALK, +18% EGFR, +13% PD-L1 in early-stage NSCLC across six community health systems, a rare deployed-AI outcomes win.Anthropic released Claude Opus 4.8 yesterday — high-effort default, dynamic workflows spawning hundreds of parallel subagents, agentic coding jumps 64.3→69.2%, ~4× fewer flawed-code passes, fast mode 3× cheaper. Pricing held at $5/$25 per M tokens.NEJM AI published the MEDS (Medical Event Data Standard) review on May 28 — an open data framework now used at 21 institutions and 27 papers that aims to fix reproducibility/portability in EHR-based clinical AI.Sources cited:businesswireMayo News NetworkNewswisePenn MedicineNEJM AIHarvard Science ReviewAnthropicTechCrunchUS NewsMEDS overviewSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

The FDA just cleared the first AI that reads burn wounds.Run time: 20:51In today's episode:FDA grants De Novo clearance to burn-reading AIEli Lilly puts five hundred million into Korean AI labQIAGEN and NVIDIA team up on AI drug discoveryBristol Myers Squibb rolls Claude to thirty thousand staffAbu Dhabi and J&J launch AI surgical networkArtera takes multimodal cancer AI to ASCOTwin Health launches AI for GLP-1 stewardshipLancet study: ChatGPT discharge summaries boost patientsClaude adds twenty-eight security and compliance toolsDeepMind hires twenty researchers from Contextual AITL;DR:The FDA granted De Novo clearance to Spectral AI's DeepView — the first AI burn-wound assessment system, opening a brand-new device category for multispectral imaging in trauma and burn care.The pharma-AI operating model deepened in one week: Eli Lilly committed $500M to a Korean AI drug-discovery hub, QIAGEN tied up with NVIDIA on BioNeMo-powered target ID, and Bristol Myers Squibb put Claude in front of ~30,000 employees.Anthropic launched the Claude Compliance API with 28 enterprise security integrations (CrowdStrike, Microsoft Purview, Wiz, Okta, Zscaler, Cloudflare and more) — the missing governance layer hospitals and pharma IT have been waiting on.Sources cited:GlobeNewswireDong-A ScienceDigital Health NewsDigital Health NewsGulf NewsBusinessWireHIT ConsultantThe Lancet Digital HealthHelp Net SecurityHeyGoTradeSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

FDA cleared does not mean it actually works. Today, the proof.Run time: 16:28In today's episode:AZmed's X-ray AI clears fractures, effusions, dislocationsFDA clears first digital-pathology breast cancer risk toolRadiologist-plus-AI beats AI alone for clot detectionTop journal: FDA cleared isn't FDA provenUltromics raises 55 million for echo AIFDA now clears an AI device every 31 hoursKPMG puts Claude in front of 276,000 staffAnthropic eyes 900-billion valuation, may pass OpenAIMicrosoft's 100 agents find 16 Windows flawsxAI ships Grok Build, its first coding agentTL;DR:A fresh wave of FDA clearances (AZmed's AZtrauma for fractures/effusions/dislocations; ArteraAI Breast) lands the same week a top journal warns that "cleared" is not "clinically proven" — the procurement question from yesterday's lung-CXR head-to-head is now everyone's problem.KPMG is rolling Claude out to 276,000+ employees as Anthropic courts a $30B raise at a $900B+ valuation that could top OpenAI for the first time.New peer-reviewed data shows radiologists plus AI beat AI alone at finding pulmonary embolism — the week's quiet through-line is collaboration and evidence, not replacement.Sources cited:Diagnostic ImagingArteraAuntMinnieAnnals of Internal MedicineCrescendo AI Healthcare NewsInnolitics 510(k) Year-in-ReviewAnthropicBloombergMicrosoft Security BlogThe DecoderSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

A saliva test just flagged cancer in under ten minutes.Run time: 20:23In today's episode:Hong Kong saliva device flags cancer in minutesAI risk scores failed to change transplant talksARPA-H funds a behavioral-health foundation modelLawsuits hit AI scribes over recorded consentAI avatar calmed cancer patients before treatmentMETiS TechBio lists on AI nanomedicine betAI matches MS patients to a repurposed drugKarpathy leaves OpenAI orbit, joins AnthropicGoogle I/O ships Gemini 3.5, Omni, and SparkClaude agents get self-hosted sandboxes and MCP tunnelsCursor's Composer 2.5 matches Opus 4.7TL;DR:A portable HKU device reads DNA-damage signals in saliva and returns a cancer-risk result via phone app in under 10 minutes — a potential cheap, non-invasive triage layer.A German RCT (PRIMA-AI) found that giving physicians AI graft-loss risk scores did NOT increase the rare-but-critical conversations about options after transplant failure — a clean reminder that prediction ≠ behavior change.Two AI-lab blockbusters landed: Andrej Karpathy joined Anthropic's pre-training team (May 19), and Google I/O unveiled Gemini 3.5 Flash, Gemini Omni (video), and the Gemini Spark agent.Sources cited:HKULucidQuest digestPR NewswireFisher PhillipsTechCrunchCNBCthe-decoderEffective context engineering for AI agentsSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

Most hospitals running AI agents have no idea if they actually work.Run time: 20:30In today's episode:Only 59 percent of health orgs track their AI agentsQure.ai Aira deployed across Mozambique's national health systemAnnalise.ai goes network-wide at Parkway SingaporeNature Medicine: clinical trials for self-updating AINature Medicine: the AI co-scientist arrives in the clinicGoogle Health Coach launches tomorrow on GeminiAnthropic Code with Claude London hits tomorrowAnthropic briefs finance regulators on Claude Mythos risksTL;DR:Healthcare IT Today's May 17 industry digest surfaced two governance numbers worth pinning above every CIO's desk: only 59% of healthcare orgs actively track the performance of their AI agents in production, and 60% of nurses say they lack confidence in their organization's AI oversight — a credibility gap that lands the same week as Aidoc's CARE foundation model and Bayesian Health's continuous-sepsis monitor scale clinically.Nature Medicine published "Clinical trials for continuously monitored and updated AI systems" by van Amsterdam, Oberst, Feng et al., proposing a conceptual framework that separates AI-intrinsic monitoring/updating from trial-oversight monitoring — the methodological companion to last week's Frontiers in Science manifesto on adaptive surgical robots and the FDA's real-time trials pilot.VillageReach and Qure.ai have deployed Aira — Qure.ai's LLM-powered co-pilot for community health workers — across Mozambique's national health system under a Gates Foundation pandemic-preparedness grant, embedding it in the AlôVida hotline and PHEOC for early signal detection across primary care; pairs with last week's Anthropic-Gates $200M deal on neglected diseases.Sources cited:Healthcare IT TodayVillageReach announcementIHH HealthcareNature MedicineNature MedicineTechCrunchClaude.comLet's Data ScienceSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

Anthropic just put two hundred million dollars into AI for diseases pharma forgot.Run time: 21:22In today's episode:Anthropic-Gates put $200M into Claude for neglected diseasesFrontiers in Science manifesto on adaptive surgical robotsNature Medicine asks is AI actually improving careCompanion Nature Medicine piece on meaningful AI evaluationnpj Digital Medicine: RL boosts LLM radiology accuracymedRxiv preprint on AI literacy micro-credentialsClaude for Small Business launches with fifteen workflowsPwC adopts Claude for enterprise deal executionTL;DR:Anthropic and the Gates Foundation announced a four-year, $200M partnership on May 14 — the headline medical pillar is Claude usage credits for research centers hunting drug candidates in HPV and preeclampsia, two indications big pharma has long skipped.Nature Medicine's May issue keeps hammering the same theme it opened the year with: "Is AI actually improving healthcare?" and a companion methodology piece argue static benchmarks are misleading and most deployed medical AI still lacks evidence of attributable clinical benefit.A Frontiers in Science consensus piece from Dasgupta and Granados (King's College London) calls for an entirely new regulatory pathway for adaptive surgical robots that "continue to learn and change after approval" — a direct shot at how FDA and notified bodies currently classify SaMD.Sources cited:Tech StartupsAnthropic newsFrontiers in ScienceNature MedicineNature Medicinenpj Digital MedicinemedRxiv preprintAnthropic newsSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

Roche just paid seven hundred fifty million dollars for an AI pathology company.Run time: 21:10In today's episode:Roche acquires PathAI in nine-figure pathology AI dealISMRM 2026 unveils whole-body MRI and AI risk modelsOpenAI publishes healthcare AI policy blueprintAccurKardia gets FDA clearance for next-gen ECG AIOpenEvidence embeds in Mount Sinai Epic at twelve billion valuationOracle Health Clinical AI Agent expands to thirty-plus specialtiesInsilico signs two point seven five billion dollar Lilly discovery pactClaude Managed Agents can now dream between sessionsAnthropic and SpaceX strike three-hundred-megawatt compute dealAnthropic doubles Claude Code rate limits across paid tiersTL;DR:Roche is acquiring PathAI for $750M upfront plus up to $300M in milestones, the first nine-figure pharma takeout of a pathology-AI pure-play and a sign foundation pathology models are becoming pharma infrastructure.ISMRM 2026 (Cape Town, May 9–14) is showcasing AI on whole-body MRI for early metabolic disease and quantitative MRI that matches mammography for dense-breast assessment — the next axis for image-based risk stratification.Anthropic shipped a research-preview "dreaming" feature for Claude Managed Agents on May 6: agents review past sessions between runs to update shared memory. Harvey reports roughly 6× task-completion gains.Sources cited:sourcesourcesourcesourcesourcesourcesourcesourcesourcesourceSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

The week AI came for the clinic. OpenAI just made ChatGPT free for every U.S. doctor.Run time: 11:39In today's episode:OpenAI ChatGPT for Clinicians free for every U.S. physicianHarvard study: o1 outscores two ER attendings on diagnosisFDA opens live data feed inside two cancer trialsOBSCORE risk model beats BMI across 18 obesity conditionsWürzburg study: patients underreport symptoms to AITopol calls out the medical-AI implementation paradoxNEJM Catalyst frames 2026 as the proof-or-pull-back yearnpj review finds bias in AI medical-education imagesEU AI Act medical high-risk obligations slip toward 2027TL;DR:OpenAI launched ChatGPT for Clinicians on May 5: free for verified U.S. physicians, NPs, PAs, and pharmacists; physician advisors rated 99.6% of nearly 7,000 test conversations safe and accurate; HealthBench Professional benchmark released alongside.Harvard / Beth Israel published in Science on May 3: OpenAI's o1 hit 67% triage accuracy on 76 ER patients vs 55% and 50% for two internal-medicine attendings.FDA opened its first real-time live data feed into two AstraZeneca and Amgen cancer trials via Paradigm Health on April 28; AI Chief Walsh projects 20 to 40% trial-time savings if expanded.Sources cited:OpenAI announcementTechCrunch summarySTAT NewsNature MedicineNature HealthGround Truths SubstackNEJM Catalystnpj Digital MedicinePetrie-Flom CenterSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

The FDA just turned on a live data feed inside two cancer trials.Run time: 15:06In today's episode:FDA pilots live cancer-trial data feedBMI-free obesity-risk model spans 18 conditionsTopol slams medical-AI implementation paradoxNEJM Catalyst declares the proof era for digital healthnpj review finds bias in AI medical-education imagesEU AI Act medical deadline shifts toward 2027npj DM perspective on EHR generative-AI traceabilityClaude Code ultrareview free preview ends May 5Claude Code ships project purge and gateway model pickerUC Berkeley shows agent benchmarks reward-hackable to 100%TL;DR:FDA opened its first live data feed into two AstraZeneca and Amgen cancer trials, projecting 20–40% timeline savings if expanded.A new Nature Medicine machine-learning model called OBSCORE risk-stratifies adults for 18 obesity-related complications using twenty everyday clinical features rather than BMI alone.Anthropic's Claude Code /ultrareview public preview is free through May 5; afterwards it bills $5–$20 per multi-agent cloud review.Sources cited:STATNature MedicineGround Truths SubstackNEJM Catalystnpj Digital MedicinePetrie-Flom Centernpj Digital MedicineAnthropic changelogReleasebot Anthropic feedBerkeley researchSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

India's biggest southern state just bought AI to find lung cancer.Run time: 21:45In today's episode:AstraZeneca and Qure.ai sign Telangana lung-cancer dealNovo Nordisk taps OpenAI for drug discoveryBerkeley and UCSF release Pillar imaging vision-language modelAmbient AI scribes ease burnout in pragmatic RCTUCSF collaborative quantifies real-world scribe time savingsDaiichi Sankyo partners with Imagene AI on oncology biomarkersMoffitt finds radiologists prefer domain-specific impression AIAnthropic launches nine creative-tool connectors including BlenderAnthropic ships Claude Design in research previewIsomorphic teases an AlphaFold-4-class drug discovery modelTL;DR:AstraZeneca and Qure.ai are scaling AI-powered lung-cancer screening across Telangana, India, signaling a population-health deployment template for the Global South.Two large studies of ambient AI scribes (a multi-site UCSF cohort and a Stanford-led pragmatic RCT) show real but modest EHR time savings and clearer burnout improvement only with frequent use.Anthropic widened Claude's creative-tools surface today with nine new MCP connectors (Blender, Adobe) and is pushing Claude Design into research preview.Sources cited:Qure.ai newsroomCNBCITN OnlineNEJM AISTATBioPharm InternationalRadiology BusinessYesil Science Digest9to5MacTechCrunchSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.